Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-24-000865
Filing Date
2024-06-14
Accepted
2024-06-14 16:14:45
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 9302
  Complete submission text file 0001593968-24-000865.txt   10770
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MERCK & CO INC ONE MERCK DRIVE PO BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address
MCGLYNN MARGARET G (Reporting) CIK: 0001215126 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 241044943